208 related articles for article (PubMed ID: 24251966)
1. Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis.
Brusch AM; Clarke RC; Platt PR; Phillips EJ
Br J Clin Pharmacol; 2014 Jul; 78(1):14-23. PubMed ID: 24251966
[TBL] [Abstract][Full Text] [Related]
2. Response to letter regarding article 'Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis'.
Brusch AM; Clarke RC; Platt PR; Phillips E
Br J Clin Pharmacol; 2014 Oct; 78(4):931-2. PubMed ID: 24611979
[No Abstract] [Full Text] [Related]
3. Letter to the authors concerning the accepted manuscript: exploring the link between pholcodine and neuromuscular anaphylaxis by Brush et al.
Uyttebroek A; Leysen J; Bridts C; Ebo D
Br J Clin Pharmacol; 2014 Oct; 78(4):929-30. PubMed ID: 24611952
[No Abstract] [Full Text] [Related]
4. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
Harboe T; Johansson SG; Florvaag E; Oman H
Allergy; 2007 Dec; 62(12):1445-50. PubMed ID: 17983379
[TBL] [Abstract][Full Text] [Related]
5. Stability of a 1.0 mg ml(-1) aqueous pholcodine solution for allergy skin testing.
Barbier P; Scala-Bertola J; Gambier N; Rivier A; Demoré B; Gillet P; Nicolas A; Petitpain N
Br J Clin Pharmacol; 2014 Nov; 78(5):1172-4. PubMed ID: 24903072
[No Abstract] [Full Text] [Related]
6. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market.
Florvaag E; Johansson SG; Irgens Å; de Pater GH
Allergy; 2011 Jul; 66(7):955-60. PubMed ID: 21241314
[TBL] [Abstract][Full Text] [Related]
7. Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents.
de Pater GH; Florvaag E; Johansson SG; Irgens Å; Petersen MN; Guttormsen AB
Allergy; 2017 May; 72(5):813-819. PubMed ID: 27859358
[TBL] [Abstract][Full Text] [Related]
8. Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolines.
Rose MA; Anderson J; Green SL; Yun J; Fernando SL
Acta Anaesthesiol Scand; 2018 May; 62(5):628-634. PubMed ID: 29368335
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between pholcodine and perioperative anaphylaxis].
Dumancić J; Marković AS
Acta Med Croatica; 2012 May; 66(2):111-4. PubMed ID: 23437637
[TBL] [Abstract][Full Text] [Related]
10. IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry.
Leysen J; De Witte L; Sabato V; Faber M; Hagendorens M; Bridts C; De Clerck L; Ebo D
Cytometry B Clin Cytom; 2013 Mar; 84(2):65-70. PubMed ID: 23355309
[TBL] [Abstract][Full Text] [Related]
11. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study.
Johansson SG; Florvaag E; Oman H; Poulsen LK; Mertes PM; Harper NJ; Garvey LH; Gerth van Wijk R; Metso T; Irgens A; Dybendal T; Halsey J; Seneviratne SL; Guttormsen AB
Allergy; 2010 Apr; 65(4):498-502. PubMed ID: 19796197
[TBL] [Abstract][Full Text] [Related]
12. Anesthesia in the patient with multiple drug allergies: are all allergies the same?
Dewachter P; Mouton-Faivre C; Castells MC; Hepner DL
Curr Opin Anaesthesiol; 2011 Jun; 24(3):320-5. PubMed ID: 21494128
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively.
Florvaag E; Johansson SG; Oman H; Venemalm L; Degerbeck F; Dybendal T; Lundberg M
Acta Anaesthesiol Scand; 2005 Apr; 49(4):437-44. PubMed ID: 15777289
[TBL] [Abstract][Full Text] [Related]
14. The pholcodine story.
Florvaag E; Johansson SG
Immunol Allergy Clin North Am; 2009 Aug; 29(3):419-27. PubMed ID: 19563989
[TBL] [Abstract][Full Text] [Related]
15. IgE-mediated anaphylactic reactions to neuromuscular blocking agents: can they be prevented?
Florvaag E; Johansson SG
Curr Allergy Asthma Rep; 2008 Sep; 8(5):375-6. PubMed ID: 18682099
[No Abstract] [Full Text] [Related]
16. Opioid non-IgE mediated effects in a BAT assay on drug hypersensitivity to pholcodine.
Chirumbolo S
Cytometry B Clin Cytom; 2014 Mar; 86(2):77. PubMed ID: 24030936
[No Abstract] [Full Text] [Related]
17. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective.
Baldo BA; Fisher MM; Pham NH
Clin Exp Allergy; 2009 Mar; 39(3):325-44. PubMed ID: 19187323
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers.
Dong S; Acouetey DS; Guéant-Rodriguez RM; Zmirou-Navier D; Rémen T; Blanca M; Mertes PM; Guéant JL
Clin Exp Allergy; 2013 Nov; 43(11):1256-62. PubMed ID: 24152158
[TBL] [Abstract][Full Text] [Related]
19. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study.
Florvaag E; Johansson SG; Oman H; Harboe T; Nopp A
Allergy; 2006 Jan; 61(1):49-55. PubMed ID: 16364156
[TBL] [Abstract][Full Text] [Related]
20. Pholcodine caused anaphylaxis in Sweden 30 years ago.
Johansson SG; Oman H; Nopp A; Florvaag E
Allergy; 2009 May; 64(5):820-1. PubMed ID: 19210354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
